Host Gene Expression Changes Correlating With Anti-HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2a

被引:17
作者
Hubbard, Jonathan J. [1 ]
Greenwell-Wild, Teresa [2 ]
Barrett, Lisa [1 ]
Yang, Jun [3 ]
Lempicki, Richard A. [3 ]
Wahl, Sharon M. [2 ]
Asmuth, David M. [4 ]
Murphy, Robert L. [5 ]
Pollard, Richard B. [4 ]
Kottilil, Shyam [1 ]
机构
[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[2] Natl Inst Dent & Craniofacial Res, Oral Infect & Immun Branch, NIH, Bethesda, MD USA
[3] SAIC Frederick Inc, Frederick, MD USA
[4] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA
[5] Northwestern Univ, Evanston, IL USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC HEPATITIS-C; PEGYLATED INTERFERON; RIBAVIRIN; REPLICATION; TRIAL; BETA;
D O I
10.1093/infdis/jis211
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated whether interferon-inducible genes (IFIGs) with known anti-human immunodeficiency virus (HIV) activity in vitro were associated with in vivo virological response in HIV infection. Nine untreated HIV-1-infected volunteers were treated for 12 weeks with peginterferon alfa-2a. A subset of IFIGs (23 of 47) increased compared with baseline through 6 weeks beyond therapy, and 10 of the 23 IFIGs significantly inversely correlated (r = 5 20.7; P < .05) with virological response. The strength of peginterferon alfa-2-ainduced IFIG response significantly correlated with declines in HIV load during treatment (r(2) = 0.87, p = .003). This study links HIV virological response to a specific IFIG subset, a potential prognostic indicator in peginterferon alfa-2a-treated patients with HIV infection.
引用
收藏
页码:1443 / 1447
页数:5
相关论文
empty
未找到相关数据